|Articles|January 11, 2022
- Pharmaceutical Executive-01-01-2022
- Volume 42
- Issue 1
Pharmaceutical Executive, January 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive January 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 4 years ago
Keeping Tabs on Quality: The Rise of Digitalabout 4 years ago
China Invests in Building Biotechabout 4 years ago
Branding Takes on a New Lookabout 4 years ago
Addressing Access Burdensabout 4 years ago
Meeting the Patient—Virtuallyabout 4 years ago
The Age of Influenceabout 4 years ago
Boosting Immunotherapiesabout 4 years ago
Pharma’s Psychedelic Experienceabout 4 years ago
Supply Chain Procurementabout 4 years ago
Our View on 2022: Pharm Exec’s Annual Industry OutlookNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5